| Product Code: ETC6207954 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 Austria Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.7 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.8 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.9 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Austria Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-Hodgkin lymphoma in Austria |
4.2.2 Technological advancements in diagnostic tools and techniques |
4.2.3 Growing awareness and early detection initiatives for lymphoma |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostic tests |
4.3.2 High cost associated with advanced diagnostic procedures |
4.3.3 Limited access to healthcare facilities in certain regions of Austria |
5 Austria Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Types |
6.1 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.1.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biomarker Test, 2021- 2031F |
6.1.7 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Genetic Test, 2021- 2031F |
6.1.8 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Cytogenetics, 2021- 2031F |
6.1.9 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Cancer Stage |
6.2.1 Overview and Analysis |
6.2.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage 0, 2021- 2031F |
6.2.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Ii, 2021- 2031F |
6.2.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iii, 2021- 2031F |
6.2.6 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iv, 2021- 2031F |
6.3 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Tumor Type |
6.3.1 Overview and Analysis |
6.3.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Aggressive Lymphomas, 2021- 2031F |
6.3.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Indolent Lymphomas, 2021- 2031F |
6.4 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Instrument Based Products, 2021- 2031F |
6.4.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Platform Based Products, 2021- 2031F |
6.4.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Kits And Reagents, 2021- 2031F |
6.4.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Other Consumables, 2021- 2031F |
6.5 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorescent In Situ Hybridization, 2021- 2031F |
6.5.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.5.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorimmunoassay, 2021- 2031F |
6.5.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.5.6 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemical, 2021- 2031F |
6.5.7 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Screening, 2021- 2031F |
6.6.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic And Predictive, 2021- 2031F |
6.6.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Prognostic, 2021- 2031F |
6.6.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Research, 2021- 2031F |
6.7 Austria Non-Hodgkin Lymphoma Diagnostics Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.6 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.7.7 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Austria Non-Hodgkin Lymphoma Diagnostics Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.8.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By , 2021- 2031F |
7 Austria Non-Hodgkin Lymphoma Diagnostics Market Import-Export Trade Statistics |
7.1 Austria Non-Hodgkin Lymphoma Diagnostics Market Export to Major Countries |
7.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Imports from Major Countries |
8 Austria Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
8.1 Average time to diagnosis for non-Hodgkin lymphoma patients in Austria |
8.2 Adoption rate of novel diagnostic technologies in the market |
8.3 Number of healthcare facilities offering specialized non-Hodgkin lymphoma diagnostic services |
8.4 Survival rates of patients diagnosed with non-Hodgkin lymphoma in Austria |
8.5 Rate of recurrence in non-Hodgkin lymphoma cases in Austria |
9 Austria Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
9.1 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.3 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.4 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.5 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Austria Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Austria Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
10.1 Austria Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Austria Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here